TOI The Oncology Institute, Inc. logo

TOI The Oncology Institute, Inc.

Healthcare
$4.54+0.00%OpenMarket Cap: $453.9M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

-286.93

P/S

0.84

EV/EBITDA

-14.62

DCF Value

$-6.20

FCF Yield

-5.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

14.8%

Operating Margin

-6.0%

Net Margin

-8.0%

ROE

326.8%

ROA

-25.9%

ROIC

-33.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$147.4M$-2.5M$
Q4 null$142.0M$-7.5M$
FY null$502.7M$-60.6M$
Q3 null$136.6M$-16.5M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$7.00

Target (Median)

$6.00

Target Range

$5.00 - $10.00

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
NeedhamBuy
2026-03-13
B. Riley SecuritiesBuy
2026-03-13
BTIGBuy
2026-03-09
BTIGBuy
2025-10-21

Trading Activity

Insider Trades

View All
Virnich Danielofficer: Chief Executive Officer
SellFri May 22
Podnos Yaleofficer: Chief Medical Officer
SellFri May 22
Carter Robert Rossofficer: Chief Financial Officer
SellFri May 22
Chernett Jorey10 percent owner
BuyThu May 21
Chernett Jorey10 percent owner
BuyThu May 21

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

US

Exchange

Beta

0.36

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

Peers